Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Hack Andrew A. F., Director. Officer active across 3 companies, notably Nuvalent, Inc.. Cumulatively, 24 disclosures have been logged. Breakdown: 10 buys · 7 sells. Total volume traded: €230.2m. Activity tracked since 9 August 2021. The latest transaction was filed on 11 December 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hack Andrew A. F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,693,014 sharesClass A Common StockSEC:0000899243-21-031627:0
24 of 24 declarations
About Hack Andrew A. F.
Administrateur, Andrew A. F. Hack is a declarant with 24 filings in total. Among the 24 most recent filings, the aggregated amounts are EUR 24,225,817 in purchases and EUR 205,942,681 in sales, over the period from 2021-08-04 to 2026-01-06; his listed companies are Mersana Therapeutics, Inc., Dynavax Technologies CORP and Nuvalent, Inc., all three with the role of Director.